Noncancer Pain
📧 Sign up to get email alerts when something new happens for Noncancer Pain.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain [NA]
This update reports the completion of a clinical trial evaluating whether medical cannabis with opioid taper support can reduce pain and low…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Usual Care Intervention Research Evaluating the Impact of a Personalized Pharmaceutical Plan on the Duration of Opioid Treatment in Non-cancerous Pain [NA]
A completed clinical trial evaluating whether a personalized pharmaceutical plan can shorten the duration of opioid treatment in chronic non…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Music as an Adjunct to Ketamine Therapy for Chronic Pain [NA]
An ongoing clinical trial is evaluating music as an adjunct to ketamine therapy for chronic pain conditions and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Evaluation of a Patient-Centred, Multidisciplinary Opioid Tapering Program for Individuals With Chronic Non-Cancer Pain on Long Term Opioid Therapy [NA]
Completed clinical trial evaluating a patient-centered, multidisciplinary opioid tapering program for individuals with chronic noncancer pai…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Retrospective Analysis of Spinal Cord Stimulation on Chronic Non-cancer Pain
This document reports a retrospective analysis evaluating the impact of spinal cord stimulation on chronic noncancer pain.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2023-12-15FDA Approved: MS CONTIN — Supplemental Application (Rhodes Pharmaceuticals L.P.)
The FDA approved Rhodes Pharmaceuticals' supplemental application for MS CONTIN (morphine sulfate), resulting in updated labeling for the pr…
-
FDA approval · 2023-12-15FDA Approved: XTAMPZA ER — Supplemental Application (Collegium Pharmaceutical, Inc.)
The FDA approved a supplemental application for XTAMPZA ER (oxycodone) submitted by Collegium Pharmaceutical, Inc., updating the product's l…
-
FDA approval · 2021-03-04FDA Approved: BELBUCA — Supplemental Application (BioDelivery Sciences International Inc)
The FDA approved a supplemental application for Belbuca (buprenorphine HCl buccal film) submitted by BioDelivery Sciences International, Inc…
-
FDA approval · 2020-04-13FDA Approved: MOVANTIK — Supplemental Application (RedHill Biopharma Ltd)
The FDA approved a supplemental application for Movantik (naloxegol oxalate) submitted by RedHill Biopharma Ltd.
-
FDA approval · 2018-02-28FDA Approved: MOVANTIK — Supplemental Application (RedHill Biopharma Ltd)
FDA approved a supplemental application for MOVANTIK (naloxegol oxalate) filed by RedHill Biopharma Ltd.
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain [Phase 3]
Phase 3 safety study of oxycodone hydrochloride and naltrexone hydrochloride extended-release capsules in adults with chronic noncancer pain…
-
FDA approval · 2016-08-22FDA Approved: MOVANTIK — Supplemental Application (RedHill Biopharma Ltd)
FDA approved a supplemental application for Movantik (naloxegol oxalate) from RedHill Biopharma Ltd.
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: Opioid Rotation From Morphine to Methadone in Treatment of Non-malignant Pain [Phase 3]
This update reports the completion of a Phase 3 trial evaluating rotating patients from morphine to methadone for non-malignant chronic pain…
-
CLINICAL_TRIALS trial_result · 2016-03-30Clinical Trial Update: Integrating Patient Reported Outcomes (I-PRO) Study for Multidisciplinary Pain Care [NA]
Sponsored by the University of Florida, the Integrating Patient Reported Outcomes (I-PRO) study in multidisciplinary pain care has completed…
-
CLINICAL_TRIALS withdrawal · 2015-12-02Clinical Trial Update: A Safety and Effectiveness Study of Prolonged Release Tapentadol Hydrochloride Among Filipino Patients With Moderate to Severe Chronic Non-Cancer Pain
The prolonged-release tapentadol hydrochloride trial in Filipino patients with moderate to severe chronic noncancer pain has been withdrawn.
-
FDA approval · 2014-04-16FDA Approved: MS CONTIN — Supplemental Application (Rhodes Pharmaceuticals L.P.)
The FDA approved a supplemental application for MS CONTIN (morphine sulfate) filed by Rhodes Pharmaceuticals L.P., signaling an update relat…
-
CLINICAL_TRIALS trial_result · 2013-11-21Clinical Trial Update: The Effectiveness and Tolerability of Fentanyl Matrix in Chronic Non-cancer Pain; Assessment of Patient's Pain Treatment Goal Achievement
A completed clinical trial evaluating the effectiveness and tolerability of the fentanyl matrix transdermal system for chronic noncancer pai…
-
CLINICAL_TRIALS trial_result · 2013-06-11Clinical Trial Update: An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Thai Participants With Chronic Non-Malignant Pain [Phase 4]
Phase 4 trial assessing efficacy and safety of a fentanyl transdermal patch in Thai participants with chronic noncancer pain; results were p…
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain [Phase 3]
Phase 3 trial update of oxycodone/naloxone for moderate to severe non-malignant (noncancer) pain, completed by Mundipharma.
-
CLINICAL_TRIALS trial_result · 2012-12-24Clinical Trial Update: A Study of the Effectiveness and Safety of Sustained-release Hydromorphone (a Strong Opioid) in Patients With Chronic Noncancer Pain. [Phase 3]
Phase 3 study assessing the effectiveness and safety of sustained-release hydromorphone for chronic noncancer pain; results have been posted…
-
CLINICAL_TRIALS trial_result · 2010-10-15Clinical Trial Update: Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant Pain [Phase 3]
This Phase 3 trial update reports the safety and efficacy of the Buprenorphine Transdermal System (BTDS) in adults with chronic noncancer pa…
-
CLINICAL_TRIALS trial_result · 2009-10-29Clinical Trial Update: Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant Pain [Phase 3]
Phase 3 trial update for Embeda (morphine sulfate/naltrexone) in adults with chronic noncancer pain; results have been posted.